Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 6.38M | $26.0M | 9.69% | +556.2K | 2026-03-31 |
| BlackRock, Inc. | 4.29M | $17.0M | 6.52% | +195.1K | 2026-03-31 |
| BRAIDWELL LP | 3.11M | $12.0M | 4.72% | -- | 2026-03-31 |
| Frazier Life Sciences Management, L.P. | 2.63M | $10.0M | 4.00% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.47M | $10.0M | 3.75% | -- | 2026-03-31 |
| Soleus Capital Management, L.P. | 2.25M | $9.0M | 3.41% | +1.18M | 2026-03-31 |
| Stonepine Capital Management, LLC | 2.18M | $8.0M | 3.31% | +547.5K | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 1.46M | $6.0M | 2.22% | -631.9K | 2026-03-31 |
| ARMISTICE CAPITAL, LLC | 1.40M | $5.0M | 2.12% | +420.0K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.38M | $5.0M | 2.10% | -4.9K | 2026-03-31 |
